Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jan 31:115:154304.
doi: 10.1016/j.tetlet.2022.154304. Epub 2022 Dec 12.

Total Synthesis of (±)- N-Methyldibromoisophakellin and N-Methylugibohlin via Net [3+2] Cycloguanidinylations Employing 2-Amido-1,3-Diamino-Allyl Cations

Affiliations

Total Synthesis of (±)- N-Methyldibromoisophakellin and N-Methylugibohlin via Net [3+2] Cycloguanidinylations Employing 2-Amido-1,3-Diamino-Allyl Cations

Nobuyuki Matsumoto et al. Tetrahedron Lett. .

Abstract

A concise total synthesis of (±)-N-methyldibromoisophakellin, a member of the monomeric pyrrole-aminoimidazole alkaloid family isolated from the marine sponge Stylissa carbica, was achieved via a net [3+2] cycloaddition to install the cyclic guanidine. This ring annulation employs a 2-amido-1,3-aminoallyl cation obtained under oxidative conditions from variously N-substituted guanidines which in one instance led to isolation of a tetracycle bearing a carbinolamine center through subsequent benzylic oxidation. Finally, the serendipitous formation of a unique, related alkenyl guanidine, N-methylugibohlin, achieved via ring opening of cyclic guanidine under acidic conditions suggests that ugibohlin may be an artifact of isolation.

Keywords: carbinolamine; guanidine; isolation artifact; pyrrole–aminoimidazole alkaloid; total synthesis.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: The authors declare no competing financial interests. Declaration of interests The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Figures

Figure 1.
Figure 1.
Tri- and tetracyclic pyrrole-aminoimidazole alkaloids (PAIs) with isomeric pyrrole connectivity and cyclic or acyclic guanidines.
Scheme 1.
Scheme 1.
Retrosynthetic analysis of (±)-N-methyldibromoisophakellin (10) employing a [3+2] cycloguanidinylation.
Scheme 2.
Scheme 2.
Attempted cycloguanidinylation with tricyclic dibromoenamide 13 and N-Ts guanidine 16. Proposed benzylic oxidation and elimination sequence leading to the observed carbinolamine 17 (inset: single crystal X-ray structure of carbinolamine 17•MeOH)
Scheme 3.
Scheme 3.
Synthesis of a bis-OMe, Cbz-guanidinylating reagent 22.
Scheme 4.
Scheme 4.
Guanidine [3+2] annulation toward (±)-N-methyldibromoisophakellin (10) leading to isomeric cyclic guanidines 26a,b and 27.
Scheme 5.
Scheme 5.
Divergent reactivity of the isomeric guanidine annulation adducts 26 and 27: synthesis of (±)-N-methydibromoisophakellin (10).
Scheme 6.
Scheme 6.
Synthesis of N-methylugibohlin (9) through ring cleavage of dibromoisophakellin core.

Similar articles

References

    1. Hoffmann H; Lindel T Synthesis of the Pyrrole-Imidazole Alkaloids. Synthesis 2003, 1753–1783. DOI: 10.1055/s-2003-41005. - DOI
    2. Forte B; Malgesini B; Piutti C; Quartieri F; Scolaro A; Papeo G A Submarine Journey: The Pyrrole-Imidazole Alkaloids. Mar. Drugs 2009, 7, 705–753. DOI: 10.3390/md7040705. - DOI - PMC - PubMed
    3. Al-Mourabit A; Zancanella MA; Tilvi S; Romo D Biosynthesis, asymmetric synthesis, and pharmacology, including cellular targets, of the pyrrole-2-aminoimidazole marine alkaloids. Nat. Prod. Rep. 2011, 28, 1229–1260. DOI: 10.1039/c0np00013b. - DOI - PMC - PubMed
    4. Beniddir MA; Evanno L; Joseph D; Skiredj A; Poupon E Emergence of diversity and stereochemical outcomes in the biosynthetic pathways of cyclobutane-centered marine alkaloid dimers. Nat. Prod. Rep. 2016, 33, 820–842. DOI: 10.1039/c5np00159e. - DOI - PubMed
    5. Seipp K; Geske L; Opatz T Marine Pyrrole Alkaloids. Mar. Drugs 2021, 19, 514. DOI: 10.3390/md19090514. - DOI - PMC - PubMed
    6. Herath AK; Lovely CJ Pyrrole carboxamide introduction in the total synthesis of pyrrole–imidazole alkaloids. Org. Biomol. Chem. 2021, 19, 2603–2621. DOI: 10.1039/d0ob02052d. - DOI - PubMed
    1. Kobayashi J; Ohizumi Y; Nakamura H; Hirata Y A novel antagonist of serotonergic receptors, hymenidin, isolated from the Okinawan marine sponge Hymeniacidon sp. Experientia 1986, 42, 1176–1177. DOI: 10.1007/BF01941300. - DOI - PubMed
    1. Burkholder PR; Sharma GM Antimicrobial agents from the sea. Lloydia 1969, 32, 466–483. - PubMed
    2. Sharma GM; Burkholder PR Structure of Dibromophakellin, a New Bromine-containing Alkaloid from the Marine Sponge Phakellia flabellata. J. Chem. Soc. Chem. D 1971, 151–152, 10.1039/C29710000151. DOI: 10.1039/C29710000151. - DOI - DOI
    3. Sharma GM; Magdoff-Fairchild B Natural products of marine sponges. 7. The constitution of weakly basic guanidine compounds, dibromophakellin and monobromophakellin. J. Org. Chem. 1977, 42, 4118–4124. DOI: 10.1021/jo00445a028. - DOI
    1. Kinnel RB; Gehrken H-P; Swali R; Skoropowski G; Scheuer PJ Palau’amine and Its Congeners: A Family of Bioactive Bisguanidines from the Marine Sponge Stylotella aurantium1. J. Org. Chem. 1998, 63, 3281–3286. DOI: 10.1021/jo971987z. - DOI
    2. Kinnel RB; Gehrken HP; Scheuer PJ Palau’amine: a cytotoxic and immunosuppressive hexacyclic bisguanidine antibiotic from the sponge Stylotella agminata. J. Am. Chem. Soc. 2002, 115, 3376–3377. DOI: 10.1021/ja00061a065. - DOI
    3. Buchanan MS; Carroll AR; Quinn RJ Revised structure of palau’amine. Tetrahedron Lett. 2007, 48, 4573–4574. DOI: 10.1016/j.tetlet.2007.04.128. - DOI
    1. Grube A; Kock M Stylissadines A and B: the first tetrameric pyrrole-imidazole alkaloids. Org. Lett. 2006, 8, 4675–4678. DOI: 10.1021/ol061317s. - DOI - PubMed
    2. Buchanan MS; Carroll AR; Addepalli R; Avery VM; Hooper JN; Quinn RJ Natural products, stylissadines A and B, specific antagonists of the P2X7 receptor, an important inflammatory target. J. Org. Chem. 2007, 72, 2309–2317. DOI: 10.1021/jo062007q. - DOI - PubMed

LinkOut - more resources